Removal of peptidoglycan and inhibition of active cellular processes leads to daptomycin tolerance in Enterococcus faecalis.
Daptomycin is a cyclic lipopeptide antibiotic used in the clinic for treatment of severe enterococcal infections. Recent reports indicate that daptomycin targets active cellular processes, specifically, peptidoglycan biosynthesis. Within, we examined the efficacy of daptomycin against Enterococcus f...
Guardado en:
Autores principales: | Rachel D Johnston, Brittni M Woodall, Johnathan Harrison, Shawn R Campagna, Elizabeth M Fozo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/09625ef076bb4301866ac20867fea31e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Daptomycin-Resistant <named-content content-type="genus-species">Enterococcus faecalis</named-content> Diverts the Antibiotic Molecule from the Division Septum and Remodels Cell Membrane Phospholipids
por: Truc T. Tran, et al.
Publicado: (2013) -
Characterization of Enterococcus faecalis in different culture conditions
por: Mi-Ah Kim, et al.
Publicado: (2020) -
Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium.
por: Clare L Kinnear, et al.
Publicado: (2020) -
Performance of Ultrasonic Process on Removal of Fecal Indicator Bacteria of Escherichia Coli and Enterococcus Faecalis from Drinking Water
por: Gholami M, Dehghanifard E, Zarghampour Z, Mirzaei R, Dehghani Nayeri M
Publicado: (2011) -
Antibiotic Resistance of Enterococcus faecalis from Persistent Endodontic Infections
por: Seguel,Natalia, et al.
Publicado: (2020)